Characteristics of Type 2 Diabetes Patients and Their Association with the Metabolic Syndrome and Cardiovascular Risk Factors at Thika Level Five Hospital in Kenya
International Journal of Diabetes and Endocrinology
Volume 4, Issue 2, June 2019, Pages: 35-48
Received: Jan. 25, 2019;
Accepted: Mar. 20, 2019;
Published: May 10, 2019
Views 127 Downloads 40
Thuita Ann Watetu, Department of Human Nutrition Sciences, School of Food and Nutrition Sciences (SoFNuS), Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Kiage Nyanchama Beatrice, Department of Human Nutrition Sciences, School of Food and Nutrition Sciences (SoFNuS), Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Onyango Arnold N., Department of Human Nutrition Sciences, School of Food and Nutrition Sciences (SoFNuS), Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Makokha Anselimo, Department of Human Nutrition Sciences, School of Food and Nutrition Sciences (SoFNuS), Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Type 2 diabetes is a public health problem and one of the most common life threatening conditions globally, due to its related complications that are usually very costly to treat, with increasing number of people being diagnosed with this condition each year. Presence of the metabolic syndrome (MetS) and cardiovascular risks in Type 2 Diabetes patients increases the risk to complications. The objective of this study was to determine characteristics of type 2 diabetes patients and their association with MetS and associated cardiovascular risk. The study employed a cross section design method. Subjects with Type 2 Diabetes were recruited for the study from Thika Level Five Hospital in Kenya. Socio-demographic, clinical and lifestyle data were obtained using questionnaires. The nutrition status was determined by anthropometry. Other laboratory parameters that were determined included total cholesterol (TC), high density cholesterol (HDL-c) and low density cholesterol (LDL-c), triglyceride (TG), fasting blood glucose (FBG), glycated haemoglobin (HbA1C), and blood pressure (BP). Overall 153 (40.5% men and 59.5% women) Type 2 diabetic patients aged 20-79 years were included in the study. The overall mean age of patients was 56.07 years. The prevalence of the metabolic syndrome was 86.3% as per WHO criteria. The MetS components were elevated waist circumference (WC, 90.8%), increased waist hip ratio (WHR, 86.9%), elevated blood pressure (65.7% & 72.5%) and elevated triglycerides (64.8%). The prevalence of occurrence of the components of the MetS was not significantly different among male and female patients except for WC, BMI and reduced serum HDL-C where women were at a significantly higher risk than men (P≤0.00.). The current study showed that income was associated with elevated diastolic blood pressure (BP), secondary education and years lived with diabetes were associated with elevated TG, while occupation showed some association with high WHR. Additionally Gender, marital status and type of residence were associated with elevated HDL while education, family history of diabetes and alcohol intake was associated with obesity. The prevalence of the MetS and associated cardiovascular risk among Type 2 Diabetes patients was high and similar among males and females. Enhanced surveillance on Mets and associated cardiovascular risk in Type 2 Diabetes in addition to application of preventive measures are critical in order to reduce the risk of macro vascular complications as well as increased cardiovascular risks in Type 2 Diabetes patients.
Thuita Ann Watetu,
Kiage Nyanchama Beatrice,
Onyango Arnold N.,
Characteristics of Type 2 Diabetes Patients and Their Association with the Metabolic Syndrome and Cardiovascular Risk Factors at Thika Level Five Hospital in Kenya, International Journal of Diabetes and Endocrinology.
Vol. 4, No. 2,
2019, pp. 35-48.
ADA; American Diabetes Association. Standards of Medical Care in Diabetes - 2018. J Clin Appl Res Educ 2018; 41.
IDF; International DiabetesFederation. Annual report. Belgium: 2014.
IDF; International Diabetes Federation. Annual Report. 2013.
IDF; International Diabetes Federation. IDF Diabetes Atlas, Seventh Edition. Brussesl, Belgium: 2015.
WHO; World Health Organization. Defination, Diagnosis and Classfication of Diabetes Mellitus and its Complication. Geneva, Switzerland: 1998.
WHO; World Health Organization. Global Report on Diabetes. Geneva, Switzerland: 2016.
IDF; International DiabetesFederation. IDF Diabetes Atlas Eighth edition. 2017. doi: http://dx.doi. org/10.1016/S0140-6736(16)31679-8.
WHO; World Health Organization. Non-Communicable Progress monitor 2017. Geneva, Switzerland: World Health Organization; 2017.
Siu PM, Yuen QS. Supplementary use of HbA1c as hyperglycemic criterion to detect metabolic syndrome. Diabetol Metab Syndr 2014; 6: 1–7. doi: 10.1186/1758-5996-6-119.
Rhee SY, Park SY, Hwang JK, Son J Il, Chin SO, Kim YS. Metabolic syndrome as an indicator of high cardiovascular risk in patients with diabetes : Analyses based on Korea National Health and Nutrition Examination Survey (KNHANES) 2008. Diabetol Metab Syndr 2014; 6: 1–9.
Osei-yeboah J, Owiredu WKBA, Norgbe GK, Lokpo SY, Gyamfi J, Allotey EA, et al. The Prevalence of Metabolic Syndrome and Its Components among People with Type 2 Diabetes in the Ho Municipality, Ghana : A Cross-Sectional Study. Hindawi Int J Chronic Dis 2017. doi: 10.1155/2017/8765804.
Tamang HK, Timilsina U, Thapa S, Singh KP, Shrestha S, Singh P, et al. Prevalence of metabolic syndrome among Nepalese type 2 diabetic patients. Nepal Med Coll J 2013; 15: 50–5.
Alberti K. G. M. M., Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the Metabolic Syndrome; A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Greenville Avenue, Dallas: 2009. doi: 10.1161/CIRCULATIONAHA.109.192644.
Hajian-Tilaki. k, Heidari. B, Bagherzadeh. M, Hajian-Tilaki. A H. Prevalence of metabolic syndrome and the association with socio-demographic characteristics and physical activity in urban population of Iranian adults: A population study. Diabetes Metab Syndr Clin Res Rev 2014; 8: 170–6. doi: 10.1016/j.dsx.2014.04.012.
Kaur J. A Comprehensive Review on Metabolic Syndrome. Cardiol Res Pract 2014.
Kaimuri M, Mwaniki P, Kombe Y. Prevalence of Metabolic Syndrome and Its Determinants among Women of Reproductive Age In Meru County, Kenya. Kenyan J Nurs Midwifery 2016; 1: 158–70.
Kengne AP, Limen SN, Sobngwi E, Djouogo CFT, Nouedoui C. Metabolic syndrome in type 2 diabetes : comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr 2012; 4: 1–8. doi: 10.1186/1758-5996-4-22.
Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr 2010; 2: 6–10. doi: 10.1186/1758-5996-2-1.
Nazaimoon W, Mohamud W, Ismail A, Sharifuddin A. Prevalence of metabolic syndrome and its risk factors in adult Malaysians : Results of a nationwide survey. Diabetes Res Clin Pract 2011; 96: 91–7. doi: 10.1016/j.diabres.2011.11.020.
Kaur J. Assessment and Screening of the Risk Factors in Metabolic Syndrome. Med Sci 2014; 2: 140–52. doi: 10.3390/medsci2030140.
Alwan AH, Alhusuny A. Assessment of Metabolic Syndrome and Its Risk Factors among Patients with Type 2 DM at Merjan Teaching Hospital, Al-Hilla City. J Dent Med Sci 2014; 13: 69–75.
Kaduka LU, Kombe Y, Kenya E, Kuria E, Bore JK, Bukania ZN, et al. Prevalence of Metabolic Syndrome Among an Urban Population in Kenya. Diabetes Care 2012; 35: 887–93. doi: 10.2337/dc11-0537.
Armitage P, Berry G, Matthews JN. Statistical Methods in Medical Research. Wileys Publication; 2008. doi: 1002/978040773666.
Lwanga S., Lemeshow S. Sample Size Determination in Health Studies- A practical Manual. 1st Edition. Geneva, Switzerland: World Health Organization; 1991.
CDC; Centre for Disease Communication. Ntaional Health and Examination Survey (NHANES): Anthropometry Procedures Manual. 2009.
WHO; World Health Organization. Global Database on Body Mass Index; BMI classification. Geneva, Switzerland: 2006.
WHO; World Health Organization. Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation. Geneva, Switzerland: 2008.
WHO; World Health Organization. Global Physical Activity Questionnaire (GPAQ) WHO STEPwise approach to NCD risk factor surveillance. n.d.
WHO; World Health Organization. Global Physical Activity Questionnaire (GPAQ) Analysis Guide. Geneva, Switzerland: 2010. doi: 10.1016/S0140-6736(12)60736-3.
Bucolo G, David H. Quantitative Determination of Serum Triglycerides by the Use of Enzymes. Clin Chem 1973; 19: 476–82.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. EnzymaticDetermination of Total Serum Cholesterol. Clin Chem 1974; 20: 470–5.
Keppy NK, Bain G, Ph D, Allen MW, Scientific TF. Enzymatic Colorimetric Methods for the Analysis of Human Serum by UV-Visible Spectroscopy. Madison, WI, USA: n.d.
Assmann G, Schriewer H, Schmltz G, Edgar-otto H. Quantification of High-Density-Lipoprotein Cholesterol by Precipitation with Phosphotungstic Acid / MgCI2. Clin Chem 1983; 29: 2026–30.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of Low-Density Lipoprotein in Plasma, Without use of the Preparative Ultracentrifuge. Clin Chem 1972; 18: 499–502.
Klenk DC, Hermanson GT, Krohn RI, Smith PK, England JD, Fujimoto K, et al. Determination of Glycosylated Hemoglobin by Affinity Chromatography : Comparison with Colorimetric and Ion-Exchange Methods, and Effects of Common Interferences. Clin Chem 1982; 28: 2088–94.
Beach EF, Turner JJ. An Enzymatic Method for Glucose Determination in Body Fluids 1958; 4: 462–75.
American Diabetes Association. Standards of Medical Care in. J Clin Appl Res Educ 2017; 36: 5–8. doi: 10.2337/dc13-S011.
AAC; American College of Cardiology. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. 2017. doi: 10.1016/j.jacc.2017.07.745.
Davidson JA, Einhorn D, Ganda OP, Garber AJ, Jellinger PS, Jovanovič L, et al. HHS Public Access 2016; 21. doi: 10.4158/EP15672.GL.To.
AACE; American Association of Clinical Endocrinologists and ACE; American College of Endocrinology. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2017 Executive Summary. Endocr Pract 2017; 23: 207–38. doi: 10.4158/EP161682.CS.
Unadike, BC; Akpan, NA; Peters, EJ; Essien IEO. Prevalence of the Metabolic Syndrome among Patients. African J Endocrinol Metab 2009; 8: 7–9.
Otero LM, Zanetti ML, Tiexeira CR de S. Sociodemographic and clinical characteristics of a diabetic population 1 at a primary level health care center 2007; 15: 768–73.
Alwan AH, Alhusuny A, Ali A, Alwan H, Medicine I, B EMBC. Assessment of Metabolic Syndrome and Its Risk Factors among Patients with Type 2 DM at Merjan Teaching Hospital, Al-Hilla City. J Dent Med Sci 2014; 13: 69–75.
Patel JL, Suthar AM, Dalsaniya VB, Parikh AP, Suthar NN, Patel KL. A Study of Metabolic Syndrome and its and their Asymptomatic First-degree Relatives. Indian J Clin Pract 2013; 23: 520–33.
Raman R, Aditi G, Swakshyar S, Pal Suganeswari G, Kadri, Venkatesh Vaitheeswaran, Kulothungan Tarun S, Access O. Prevalence of Metabolic Syndrome and its influence on microvascular complications in the Indian population with Type 2 Diabetes Mellitus. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study. Diabetol Metab Syndr 2010; 2: 1–9. doi: 10.1186/1758-5996-2-67.
Moreira SS, Andrade CDS, Antonio C, Teles DS, Neves RCS. Correlates of poor glycemic control in patients with type 2 diabetes : results of a nationwide survey in Brazil. Diabetol Metab Syndr 2015; 7: A55. doi: 10.1186/1758-5996-7-S1-A55.
Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes : a conspiracy of disease, suboptimal therapy and attitude. J Med 2000: 369–74.
Tamara B. Horwich GCF. Glucose, Obesity, Metabolic Syndrome, and Diabetes: Relevance to Incidence of Heart Failure. J Am Coll Cardiol 2010; 55: 283–93. doi: 10.1016/j.jacc.2009.07.029. Glucose.
Rodrigues TC, Canani LH, Gross JL. Review Article Metabolic Syndrome, Insulin Resistance and Cardiovascular Disease in Type-1 Diabetes Mellitus. Cardiovasc Dis Type-1 Diabetes Mellit 2008: 125–30.
Hu H, Hori A, Nishiura C, Sasaki N, Okazaki H. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes : Japan Epidemiology Collaboration on Occupational Health Study. PLoS One 2016; 11: 1–13. doi: 10.1371/journal.pone.0159071.
Godwill EA, Okolie A, Nwalo F, Akaniro-ejim NE. Association of Obesity and Dyslipidaemia with Type 2 Diabetes in Outpatients of Enugu State University Teaching Hospital (ESUTH) in Enugu Nigeria. J Life Sci 2018; 12. doi: 10.17265/1934-7391/2018.02.003.
Firouzi S, Nisak B, Yusof M, Kamaruddin NA. Nutritional status, glycemic control and its associated risk factors among a sample of type 2 diabetic individuals, a pilot study 2015.
Tadewos A, Ambachew H, Assegu D. Pattern of Metabolic Syndrome in Relation to Gender among Type-II DM Patients in Hawassa University Comprehensive Specialized Hospital, Hawassa,. Heaalth Sci J 2017; 11: 509. doi: 10.21767/1791-809X.1000509.
Mavarez-Martinez A, Gonzalez-Zacarias AA, Stoicea N, Rogers B, Arias-Morales CE. Impact of Demographic, Socioeconomic, and Psychological Factors on Glycemic Self-Management in Adults with Type 2 Diabetes Mellitus. Front Public Heal 2016; 4: 1–8. doi: 10.3389/fpubh.2016.00195.
Barlin H, Mercan M. Occupation and Obesity : Effect of Working Hours on Obesity by Occupation Occupation and Obesity : Effect of Working Hours on Obesity by Occupation Groups 2016. doi: 10.11114/aef.v3i2.1351.
Ogunsina K, Dibaba DT, Akinyemiju T. Status and prevalence of cardio-metabolic risk factors in five middle-income countries 2018; 8: 1–10. doi: 10.7189/jogh.08.020405.
Gopalakrishnan S, Geetha A, R U. Study on the impact of family history of diabetes among type 2 diabetes mellitus patients in an urban area of Kancheepuram district, Tamil Nadu. Int J Community Med Public Heal 2017; 4. doi: 10.18203/2394-6040.ijcmph20174819.